La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Success rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease

Identifieur interne : 000E25 ( Main/Exploration ); précédent : 000E24; suivant : 000E26

Success rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease

Auteurs : A. H. V. Schapira [Royaume-Uni] ; P. Barone [Italie] ; R. A. Hauser [États-Unis] ; Y. Mizuno [Japon] ; O. Rascol [France] ; M. Busse [Allemagne] ; C. Debieuvre [France] ; M. Fraessdorf [Allemagne] ; Werner Poewe [Autriche]

Source :

RBID : ISTEX:D7025C3A7E3D3975ECD69DFF8D05E87291AE2BF5

Abstract

For Parkinson's disease (PD), an extended‐release (ER) pramipexole formulation taken once daily, has shown efficacy, safety, and tolerability resembling those of immediate‐release (IR) pramipexole taken three times daily. The present study assessed, in advanced PD, the success of an overnight switch from adjunctive IR to ER.

Url:
DOI: 10.1111/j.1468-1331.2012.03822.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Success rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease</title>
<author>
<name sortKey="Schapira, A H V" sort="Schapira, A H V" uniqKey="Schapira A" first="A. H. V." last="Schapira">A. H. V. Schapira</name>
</author>
<author>
<name sortKey="Barone, P" sort="Barone, P" uniqKey="Barone P" first="P." last="Barone">P. Barone</name>
</author>
<author>
<name sortKey="Hauser, R A" sort="Hauser, R A" uniqKey="Hauser R" first="R. A." last="Hauser">R. A. Hauser</name>
</author>
<author>
<name sortKey="Mizuno, Y" sort="Mizuno, Y" uniqKey="Mizuno Y" first="Y." last="Mizuno">Y. Mizuno</name>
</author>
<author>
<name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O." last="Rascol">O. Rascol</name>
</author>
<author>
<name sortKey="Busse, M" sort="Busse, M" uniqKey="Busse M" first="M." last="Busse">M. Busse</name>
</author>
<author>
<name sortKey="Debieuvre, C" sort="Debieuvre, C" uniqKey="Debieuvre C" first="C." last="Debieuvre">C. Debieuvre</name>
</author>
<author>
<name sortKey="Fraessdorf, M" sort="Fraessdorf, M" uniqKey="Fraessdorf M" first="M." last="Fraessdorf">M. Fraessdorf</name>
</author>
<author>
<name sortKey="Poewe, W" sort="Poewe, W" uniqKey="Poewe W" first="W." last="Poewe">Werner Poewe</name>
<affiliation>
<country>Autriche</country>
<placeName>
<settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D7025C3A7E3D3975ECD69DFF8D05E87291AE2BF5</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1111/j.1468-1331.2012.03822.x</idno>
<idno type="url">https://api.istex.fr/document/D7025C3A7E3D3975ECD69DFF8D05E87291AE2BF5/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000855</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000855</idno>
<idno type="wicri:Area/Istex/Curation">000855</idno>
<idno type="wicri:Area/Istex/Checkpoint">000032</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000032</idno>
<idno type="wicri:doubleKey">1351-5101:2013:Schapira A:success:rate:efficacy</idno>
<idno type="wicri:Area/Main/Merge">000E53</idno>
<idno type="wicri:Area/Main/Curation">000E25</idno>
<idno type="wicri:Area/Main/Exploration">000E25</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Success rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease</title>
<author>
<name sortKey="Schapira, A H V" sort="Schapira, A H V" uniqKey="Schapira A" first="A. H. V." last="Schapira">A. H. V. Schapira</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Neurosciences, University College London Institute of Neurology, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Royaume-Uni</country>
</affiliation>
</author>
<author>
<name sortKey="Barone, P" sort="Barone, P" uniqKey="Barone P" first="P." last="Barone">P. Barone</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Italie</country>
<wicri:regionArea>University of Salerno, Naples</wicri:regionArea>
<wicri:noRegion>Naples</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hauser, R A" sort="Hauser, R A" uniqKey="Hauser R" first="R. A." last="Hauser">R. A. Hauser</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of South Florida College of Medicine, FL, Tampa</wicri:regionArea>
<wicri:noRegion>Tampa</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mizuno, Y" sort="Mizuno, Y" uniqKey="Mizuno Y" first="Y." last="Mizuno">Y. Mizuno</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Kitasato University School of Medicine, Kanagawa</wicri:regionArea>
<wicri:noRegion>Kanagawa</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O." last="Rascol">O. Rascol</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinical Investigation Center INSERM CIC‐9302 and Departments of Clinical Pharmacology and Neurosciences, Toulouse University Hospital, Toulouse</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Busse, M" sort="Busse, M" uniqKey="Busse M" first="M." last="Busse">M. Busse</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Boehringer Ingelheim GmbH, Ingelheim am Rhein</wicri:regionArea>
<wicri:noRegion>Ingelheim am Rhein</wicri:noRegion>
<wicri:noRegion>Ingelheim am Rhein</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Debieuvre, C" sort="Debieuvre, C" uniqKey="Debieuvre C" first="C." last="Debieuvre">C. Debieuvre</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Boehringer Ingelheim France S.A.S, Reims</wicri:regionArea>
<placeName>
<region type="region">Grand Est</region>
<region type="old region">Champagne-Ardenne</region>
<settlement type="city">Reims</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Fraessdorf, M" sort="Fraessdorf, M" uniqKey="Fraessdorf M" first="M." last="Fraessdorf">M. Fraessdorf</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Boehringer Ingelheim GmbH, Ingelheim am Rhein</wicri:regionArea>
<wicri:noRegion>Ingelheim am Rhein</wicri:noRegion>
<wicri:noRegion>Ingelheim am Rhein</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Poewe, W" sort="Poewe, W" uniqKey="Poewe W" first="W." last="Poewe">Werner Poewe</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Innsbruck Medical University, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
<placeName>
<settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">European Journal of Neurology</title>
<title level="j" type="abbrev">Eur J Neurol</title>
<idno type="ISSN">1351-5101</idno>
<idno type="eISSN">1468-1331</idno>
<imprint>
<publisher>Blackwell Publishing Ltd</publisher>
<date type="published" when="2013-01">2013-01</date>
<biblScope unit="volume">20</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="180">180</biblScope>
<biblScope unit="page" to="187">187</biblScope>
</imprint>
<idno type="ISSN">1351-5101</idno>
</series>
<idno type="istex">D7025C3A7E3D3975ECD69DFF8D05E87291AE2BF5</idno>
<idno type="DOI">10.1111/j.1468-1331.2012.03822.x</idno>
<idno type="ArticleID">ENE3822</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1351-5101</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">For Parkinson's disease (PD), an extended‐release (ER) pramipexole formulation taken once daily, has shown efficacy, safety, and tolerability resembling those of immediate‐release (IR) pramipexole taken three times daily. The present study assessed, in advanced PD, the success of an overnight switch from adjunctive IR to ER.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Autriche</li>
<li>France</li>
<li>Italie</li>
<li>Japon</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region>
<li>Angleterre</li>
<li>Champagne-Ardenne</li>
<li>Grand Est</li>
<li>Grand Londres</li>
<li>Midi-Pyrénées</li>
<li>Occitanie (région administrative)</li>
<li>Tyrol (Land)</li>
</region>
<settlement>
<li>Innsbruck</li>
<li>Londres</li>
<li>Reims</li>
<li>Toulouse</li>
</settlement>
<orgName>
<li>Université de médecine d'Innsbruck</li>
</orgName>
</list>
<tree>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Schapira, A H V" sort="Schapira, A H V" uniqKey="Schapira A" first="A. H. V." last="Schapira">A. H. V. Schapira</name>
</region>
<name sortKey="Schapira, A H V" sort="Schapira, A H V" uniqKey="Schapira A" first="A. H. V." last="Schapira">A. H. V. Schapira</name>
</country>
<country name="Italie">
<noRegion>
<name sortKey="Barone, P" sort="Barone, P" uniqKey="Barone P" first="P." last="Barone">P. Barone</name>
</noRegion>
</country>
<country name="États-Unis">
<noRegion>
<name sortKey="Hauser, R A" sort="Hauser, R A" uniqKey="Hauser R" first="R. A." last="Hauser">R. A. Hauser</name>
</noRegion>
</country>
<country name="Japon">
<noRegion>
<name sortKey="Mizuno, Y" sort="Mizuno, Y" uniqKey="Mizuno Y" first="Y." last="Mizuno">Y. Mizuno</name>
</noRegion>
</country>
<country name="France">
<region name="Occitanie (région administrative)">
<name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O." last="Rascol">O. Rascol</name>
</region>
<name sortKey="Debieuvre, C" sort="Debieuvre, C" uniqKey="Debieuvre C" first="C." last="Debieuvre">C. Debieuvre</name>
</country>
<country name="Allemagne">
<noRegion>
<name sortKey="Busse, M" sort="Busse, M" uniqKey="Busse M" first="M." last="Busse">M. Busse</name>
</noRegion>
<name sortKey="Fraessdorf, M" sort="Fraessdorf, M" uniqKey="Fraessdorf M" first="M." last="Fraessdorf">M. Fraessdorf</name>
</country>
<country name="Autriche">
<region name="Tyrol (Land)">
<name sortKey="Poewe, W" sort="Poewe, W" uniqKey="Poewe W" first="W." last="Poewe">Werner Poewe</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E25 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000E25 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D7025C3A7E3D3975ECD69DFF8D05E87291AE2BF5
   |texte=   Success rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024